2025 年全球口服药物传输系统市场报告

预计未来几年口服药物输送系统的市场规模将快速成长。到 2029 年，这一数字将成长至 59.7 亿美元，复合年增长率为 11.1%。预测期内的增长可归因于以患者为中心的药物输送、老年人口的增长、对标靶治疗、生技药品和胜肽输送的需求、监管支持和核准以及对研发的投资。预测期内的关键趋势包括患者的便利性和依从性、药物配方的进步、慢性病的增加、儿科和老年护理以及生物有效性的提高。

预计慢性病发病率的不断上升将推动未来几年口服药物输送系统市场的成长。慢性病是指持续一年以上的健康状况，例如癌症、心臟病、中风、糖尿病或关节炎。这些疾病是最常见的慢性疾病，可以控制但无法治愈，需要持续的医疗和营养支持。口服给药系统为黏膜和粘膜药物的给药提供了一种有效、方便的方法，这是许多患有糖尿病和癌症等慢性疾病的患者所需要的。例如，2023年9月，总部设在瑞士的联合国专门机构世界卫生组织（WHO）报告称，非传染性疾病（NCD）或慢性病每年导致4,100万人死亡，占死亡总数的74%。其中，心血管疾病导致1,790万人死亡，癌症造成930万人死亡，慢性呼吸道疾病导致410万人死亡，糖尿病导致200万人死亡。因此，慢性病的日益普及正在推动口服药物输送系统市场的成长。

预计未来几年医院需求的不断增长将推动口服药物输送系统市场的成长。医院是为生病或受伤的人提供治疗、护理和服务的专门机构。在医院环境中，口服药物传输系统具有药物吸收迅速、病患依从性增强、胃肠道副作用减少和药物释放控制等优点。例如，2023 年 5 月，代表医院和医疗保健网路的美国医疗保健贸易组织美国医院协会 (AHA) 报告称，医院总数从 2022 年的 6,093 家增加到 6,129 家。此外，美国所有医院的住院总数为 34,011,386 人次，高于 2022 年的 33,356,853 人次。因此，医院不断增长的需求正在推动口服药物输送系统市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球口服药物输送系统市场的 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
• 最终用途产业分析
• 全球口服药物输送系统市场：成长率分析
• 全球口服药物输送系统市场表现：规模与成长，2019 年至 2024 年
• 全球口服药物传递系统市场预测：规模与成长，2024-2029 年，2034 年
• 口服给药系统的全球总目标市场 (TAM)

第六章 市场细分

• 全球口服药物输送系统市场类型、表现及预测，2019-2024、2024-2029、2034
• 舌下
• 口服锭剂及含片
• 口腔喷雾剂
• 全球口服药物传递系统市场（按应用、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 疼痛管理
• 禁止抽烟
• 心绞痛
• 全球口服药物输送系统市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
• 医院
• 门诊中心
• 其他的
• 全球口服给药系统市场：舌下给药按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 舌下片
• 舌下含片
• 全球口服药物输送系统市场：颊锭剂和含片按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 颊锭剂
• 口服锭剂
• 全球口服给药系统市场：口腔喷雾剂按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 喷雾液
• 喷雾啫咖哩

第七章 区域和国家分析

• 全球口服药物输送系统市场各地区、绩效及预测，2019-2024、2024-2029、2034
• 全球口服药物输送系统市场（依国家划分）、绩效及预测，2019-2024、2024-2029、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• 口服药物输送系统市场：竞争格局
• 口服药物输送系统市场：公司简介
  • Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
  • Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Catalent Inc.
• Arx Limited Liability Company
• BioDelivery Science International Incorporated
• Cynapsus Therapeutics Incorporated
• Endo Pharmaceuticals Public Limited Company
• Medlab Clinical Ltd.
• AstraZeneca PLC
• F Hoffmann-La Roche Limited
• Dr. Reddy's Laboratories Ltd.
• Takeda Pharmaceutical Company Limited
• Novartis AG
• Novo Nordisk A/S
• Ethypharm SAS
• Applied Pharma Research SA
• Sunovion Pharmaceuticals Inc.

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年口服药物输送系统市场：提供新机会的国家
• 口服药物输送系统市场 2029：提供新机会的细分市场
• 口服药物输送系统市场 2029：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

The buccal drug delivery system involves administering the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for delivering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

The main types of buccal drug delivery systems include sublingual, buccal tablets and lozenges, and oral sprays. The term sublingual refers to the route of administration for systemic medication delivery of buccal drugs. These are applied in various applications such as pain management, smoking cessation, and angina pectoris, and are utilized by hospitals, ambulatory care centers, and other healthcare facilities.

The buccal drug delivery system market research report is one of a series of new reports from The Business Research Company that provides buccal drug delivery system market statistics, including buccal drug delivery system industry global market size, regional shares, competitors with a buccal drug delivery system market share, detailed buccal drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the buccal drug delivery system industry. This buccal drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal drug delivery system market size has grown rapidly in recent years. It will grow from $3.55 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease-specific applications.

The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $5.97 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to patient-centric drug delivery, rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support and approvals, investments in r&d. Major trends in the forecast period include patient convenience and compliance, advancements in drug formulations, rise in chronic diseases, pediatric and geriatric care, enhanced bioavailability.

The increasing prevalence of chronic diseases is anticipated to boost the growth of the buccal drug delivery systems market in the future. Chronic diseases are defined as health conditions that last for a year or more, including cancer, heart disease, stroke, diabetes, and arthritis. These illnesses are among the most common chronic conditions that can be managed but not cured, requiring ongoing medical care and nutrition. Buccal drug delivery systems offer an effective and suitable method for administering mucosal and transmucosal drugs needed by many patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths, accounting for 74% of global deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur each year. Among these, there were 17.9 million deaths due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is driving the growth of the buccal drug delivery systems market.

The rising demand in hospitals is expected to drive the growth of the buccal drug delivery systems market in the future. Hospitals are specialized facilities that provide medical treatment, care, and services to individuals who are ill or injured. In hospital settings, buccal drug delivery systems offer benefits such as rapid drug absorption, enhanced patient compliance, reduced gastrointestinal side effects, and controlled drug release. For example, in May 2023, a report from the American Hospital Association (AHA), a US-based healthcare trade organization representing hospitals and healthcare networks, indicated that the total number of hospitals increased to 6,129, up from 6,093 in 2022. Additionally, total admissions across all U.S. hospitals rose to 34,011,386, compared to 33,356,853 in 2022. Thus, the increasing demand in hospitals is propelling the growth of the buccal drug delivery systems market.

Leading companies in the buccal drug delivery systems market are concentrating on creating innovative solutions, such as oral treatments for plaque psoriasis, to enhance patient outcomes and improve drug delivery efficacy. Oral treatments for plaque psoriasis involve administering medications by mouth to manage and relieve the symptoms of this chronic autoimmune disorder, which is characterized by the rapid proliferation of skin cells resulting in thick, red, scaly patches. For example, in September 2022, Bristol Myers Squibb, a US-based pharmaceutical company, received FDA approval for Sotyktu (deucravacitinib), an oral treatment for adults suffering from moderate-to-severe plaque psoriasis. This approval represents the first new oral therapy for this condition in nearly a decade, introducing a novel mechanism of action as a selective inhibitor of tyrosine kinase 2 (TYK2).

Companies operating in the buccal drug delivery systems market are focusing on product launches to drive revenues. For instance, in February 2023, launch of melatonin oral spray by Arlak Biotech Private Limited. Melatonin oral spray provides an easy and effective way to facilitate the body's natural production of melatonin, aiding in improving sleep quality. This type of product launch addresses specific healthcare needs, contributing to the growth of the buccal drug delivery systems market.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical company, acquired Aveva Drug Delivery Services Inc. This strategic acquisition aimed to enhance DifGen's research and development (R&D) and manufacturing capabilities, ensuring a secure supply of high-quality and cost-effective medications. Aveva Drug Delivery Services Inc. specializes in buccal drug delivery systems, aligning with DifGen's goal of providing advanced and reliable pharmaceutical solutions.

Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy's Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.

North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The buccal drug delivery system market consists of the sales of drug ingredients such as insulin, nicotine, tizanidine, triptan, nifedipine, flurbiprofen, sodium carboxymethylcellulose, carbopol, glibenclamide, hyaluronic acid, and xanthan gum. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Buccal Drug Delivery System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on buccal drug delivery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for buccal drug delivery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The buccal drug delivery system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Sublingual; Buccal Tablets And Lozenges; Oral Sprays
• 2) By Application: Pain Management; Smoking Cessation; Angina Pectoris
• 3) By End-User: Hospitals; Ambulatory Centers; Other End-Users
• Subsegments:
• 1) By Sublingual: Sublingual Tablets; Sublingual Films
• 2) By Buccal Tablets And Lozenges: Buccal Tablets; Buccal Lozenges
• 3) By Oral Sprays: Spray Solutions; Spray Gels
• Companies Mentioned: Teva Pharmaceuticals Industries Ltd.; Pfizer Incorporated; GlaxoSmithKline Public Limited Company; Indivior PLC; Generex Biotechnology Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Buccal Drug Delivery System Market Characteristics

3. Buccal Drug Delivery System Market Trends And Strategies

4. Buccal Drug Delivery System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Buccal Drug Delivery System Growth Analysis And Strategic Analysis Framework

• 5.1. Global Buccal Drug Delivery System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Buccal Drug Delivery System Market Growth Rate Analysis
• 5.4. Global Buccal Drug Delivery System Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Buccal Drug Delivery System Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Buccal Drug Delivery System Total Addressable Market (TAM)

6. Buccal Drug Delivery System Market Segmentation

• 6.1. Global Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sublingual
• Buccal Tablets And Lozenges
• Oral Sprays
• 6.2. Global Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Smoking Cessation
• Angina Pectoris
• 6.3. Global Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Centers
• Other End-Users
• 6.4. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Sublingual, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sublingual Tablets
• Sublingual Films
• 6.5. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Buccal Tablets And Lozenges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal Tablets
• Buccal Lozenges
• 6.6. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Oral Sprays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spray Solutions
• Spray Gels

7. Buccal Drug Delivery System Market Regional And Country Analysis

• 7.1. Global Buccal Drug Delivery System Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Buccal Drug Delivery System Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Buccal Drug Delivery System Market

• 8.1. Asia-Pacific Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Buccal Drug Delivery System Market

• 9.1. China Buccal Drug Delivery System Market Overview
• 9.2. China Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Buccal Drug Delivery System Market

• 10.1. India Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Buccal Drug Delivery System Market

• 11.1. Japan Buccal Drug Delivery System Market Overview
• 11.2. Japan Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Buccal Drug Delivery System Market

• 12.1. Australia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Buccal Drug Delivery System Market

• 13.1. Indonesia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Buccal Drug Delivery System Market

• 14.1. South Korea Buccal Drug Delivery System Market Overview
• 14.2. South Korea Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Buccal Drug Delivery System Market

• 15.1. Western Europe Buccal Drug Delivery System Market Overview
• 15.2. Western Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Buccal Drug Delivery System Market

• 16.1. UK Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Buccal Drug Delivery System Market

• 17.1. Germany Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Buccal Drug Delivery System Market

• 18.1. France Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Buccal Drug Delivery System Market

• 19.1. Italy Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Buccal Drug Delivery System Market

• 20.1. Spain Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Buccal Drug Delivery System Market

• 21.1. Eastern Europe Buccal Drug Delivery System Market Overview
• 21.2. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Buccal Drug Delivery System Market

• 22.1. Russia Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Buccal Drug Delivery System Market

• 23.1. North America Buccal Drug Delivery System Market Overview
• 23.2. North America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Buccal Drug Delivery System Market

• 24.1. USA Buccal Drug Delivery System Market Overview
• 24.2. USA Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Buccal Drug Delivery System Market

• 25.1. Canada Buccal Drug Delivery System Market Overview
• 25.2. Canada Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Buccal Drug Delivery System Market

• 26.1. South America Buccal Drug Delivery System Market Overview
• 26.2. South America Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Buccal Drug Delivery System Market

• 27.1. Brazil Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Buccal Drug Delivery System Market

• 28.1. Middle East Buccal Drug Delivery System Market Overview
• 28.2. Middle East Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Buccal Drug Delivery System Market

• 29.1. Africa Buccal Drug Delivery System Market Overview
• 29.2. Africa Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Buccal Drug Delivery System Market Competitive Landscape And Company Profiles

• 30.1. Buccal Drug Delivery System Market Competitive Landscape
• 30.2. Buccal Drug Delivery System Market Company Profiles
  • 30.2.1. Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Buccal Drug Delivery System Market Other Major And Innovative Companies

• 31.1. Catalent Inc.
• 31.2. Arx Limited Liability Company
• 31.3. BioDelivery Science International Incorporated
• 31.4. Cynapsus Therapeutics Incorporated
• 31.5. Endo Pharmaceuticals Public Limited Company
• 31.6. Medlab Clinical Ltd.
• 31.7. AstraZeneca PLC
• 31.8. F Hoffmann-La Roche Limited
• 31.9. Dr. Reddy's Laboratories Ltd.
• 31.10. Takeda Pharmaceutical Company Limited
• 31.11. Novartis AG
• 31.12. Novo Nordisk A/S
• 31.13. Ethypharm SAS
• 31.14. Applied Pharma Research SA
• 31.15. Sunovion Pharmaceuticals Inc.

32. Global Buccal Drug Delivery System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market

34. Recent Developments In The Buccal Drug Delivery System Market

35. Buccal Drug Delivery System Market High Potential Countries, Segments and Strategies

• 35.1 Buccal Drug Delivery System Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Buccal Drug Delivery System Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Buccal Drug Delivery System Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer